MedicaidCoverageMedium impact
BT2024164: IHCP removes coverage for voxelotor (Oxbryta)
Indiana Medicaid (IHCP)·IN · Hematology, Oncology, Internal Medicine +2 more·Medical Policy
Effective date
Oct 2, 2024
We identified it
Jun 19, 2026
Summary
IHCP (Indiana Medicaid) has immediately removed coverage for voxelotor (Oxbryta) effective October 2, 2024, following FDA's voluntary market withdrawal recommendation. All claims for this sickle cell disease medication will no longer be reimbursed.
Action Required
Immediately: Stop submitting claims for voxelotor (Oxbryta) to Indiana Medicaid for dates of service October 2, 2024 and after. Providers must contact patients currently on Oxbryta to discuss discontinuation and alternative treatment options. Update medication lists and prior authorization requests to remove this drug. Contact Optum Rx Clinical Help Desk at 855-577-6317 for questions about alternative carved-out medications.